![](/img/cover-not-exists.png)
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial
M. A. Nauck, G. Meininger, D. Sheng, L. Terranella, P. P. Stein, Sitagliptin Study 024 GroupVolume:
9
Year:
2007
Language:
english
Pages:
12
DOI:
10.1111/j.1463-1326.2006.00704.x
File:
PDF, 191 KB
english, 2007